|
481 |
Population–versus Cohort–Based Modelling Approaches
Enthalten in PharmacoEconomics Bd. 30, 11.10.2012, Nr. 3, date:3.2012: 171-181
|
|
|
|
482 |
Potential Anti-Vascular Endothelial Growth Factor Therapies for Central Retinal Vein Occlusion
Enthalten in Drugs Bd. 72, 25.12.2012, Nr. 16, date:12.2012: 2063-2071
|
|
|
|
483 |
Potential Medication Problems in Older Newly Diagnosed Cancer Patients in Canada during Cancer Treatment
Enthalten in Drugs & aging Bd. 27, 11.9.2012, Nr. 7, date:7.2010: 559-572
|
|
|
|
484 |
Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus
Enthalten in Clinical drug investigation Bd. 32, 29.8.2012, Nr. 1, date:1.2012: 1-14
|
|
|
|
485 |
Predicting Direct Costs of HIV Care During the First Year of Darunavir-Based Highly Active Antiretroviral Therapy Using CD4 Cell Counts
Enthalten in PharmacoEconomics Bd. 28, 14.10.2012, Nr. 1, date:12.2010: 169-181
|
|
|
|
486 |
Prediction of Immunogenicity of Therapeutic Proteins
Enthalten in BioDrugs Bd. 24, 16.8.2012, Nr. 1, date:2.2010: 1-8
|
|
|
|
487 |
Predictive Performance of a Recently Developed Population Pharmacokinetic Model for Morphine and its Metabolites in New Datasets of (Preterm) Neonates, Infants and Children
Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 1, date:1.2011: 51-63
|
|
|
|
488 |
Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting
Enthalten in American journal of cardiovascular drugs Bd. 10, 17.8.2012, Nr. 1, date:2.2010: 37-48
|
|
|
|
489 |
Pregnancy Dermatoses
Enthalten in American journal of clinical dermatology Bd. 12, 10.9.2012, Nr. 1, date:2.2011: 25-41
|
|
|
|
490 |
Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals
Enthalten in Drug safety Bd. 35, 13.12.2012, Nr. 6, date:6.2012: 471-480
|
|
Administration
